Doximity, Inc.
NYSE:DOCSMedical - Healthcare Information Services
-$0.09 today
- Market cap
- $5.47B
- Beta
- 1.29
- P/E (TTM)
- 19.2
- EPS (TTM)
- $1.06
Volume 2.27M
Average 3.89M
DOCS Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
Doximity, Inc.NYSE: DOCS
Other Non-Cash Items · Q2 FY2027 · quarter ended Sep 2026
Other non-cash items growth accelerates
Q2 FY2027 other non-cash items of $22.26M rose 1461.9% year over year, ahead of the -90.5% change in trailing-twelve-month other non-cash items. Over 3 fiscal years it compounded at -21.5% a year.
Context
- Other non-cash items amounted to 1.2% of revenue in FY2026, up 0.8 pp from a year earlier.
- Other non-cash items increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +1461.9% holds above the trailing-twelve-month pace of -90.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2026
- 7.96M USD
- Year-over-year change
- +192.1%
- 4-year CAGR
- -17.1%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 7.96M | +192.1% |
| FY2025 | 2025-03-31 | 2.72M | -67.1% |
| FY2024 | 2024-03-31 | 8.29M | -49.7% |
| FY2023 | 2023-03-31 | 16.47M | -2.4% |
| FY2022 | 2022-03-31 | 16.89M | — |
Other Non-Cash Items vs competitors
How DOCS compares with its peers on the latest reported figures
- DOCS's LTM Sep 2026 other non-cash items of $4.65M is the 8th largest of the 10 companies compared; the peer median is $45.68M.
- Its year-over-year change of -90.5% is the 8th highest of 10, against a peer median of +76.3%.
- Other non-cash items amounts to 0.7% of revenue for DOCS, versus a peer median of 3.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.7B | -35.5% | — | 18.3% | |
| LTM Jun 2026 | $1.51B | -3306.4% | — | 18.1% | |
| LTM Jun 2026 | $725.89M | +447.2% | +80.6% | 8.8% | |
| LTM Jul 2026 | $565.6M | +540.5% | +22.4% | 13.3% | |
| LTM Jul 2026 | $86.15M | +195.3% | +6.2% | 3.0% | |
| LTM Sep 2026 | $45.68M | +76.3% | -36.0% | 3.6% | |
| LTM Jun 2026 | $30.5M | +154.2% | +53.9% | 0.5% | |
| LTM Sep 2026 | $4.65M | -90.5% | -21.5% | 0.7% | |
| LTM Jul 2026 | $919K | -66.6% | -33.0% | 0.1% | |
| LTM Sep 2026 | $709K | -96.9% | +17.1% | 0.0% | |
| Peer median (excluding DOCS) | $45.68M | +76.3% | +17.1% | 3.6% | |
Competitors are the stored peer set for DOCS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Net Income | 154.78M | 112.82M | 147.58M | 223.19M | 196.05M |
| Depreciation & Amortization | 5.04M | 10.28M | 10.27M | 10.66M | 14.38M |
| Deferred Income Tax | (41.25M) | 13.23M | (8.59M) | (11.59M) | 32.14M |
| Stock-Based Compensation | 31.44M | 47.83M | 51.08M | 72.39M | 121.63M |
| Change in Working Capital | (40.33M) | (21.03M) | (24.52M) | (24.1M) | (45.7M) |
| Accounts Receivables | (31.02M) | (26.24M) | 3.99M | (27.21M) | (16.88M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 8.66M | (195K) | 8.33M | (663K) | 4.27M |
| Other Working Capital | (17.98M) | 5.4M | (36.85M) | 3.77M | (33.09M) |
| Other Non-Cash Items | 16.89M | 16.47M | 8.29M | 2.72M | 7.96M |
| Operating Cash Flow | 126.58M | 179.6M | 184.1M | 273.27M | 326.46M |
| Capital Expenditures | (5.7M) | (6.18M) | (5.8M) | (6.53M) | (8.96M) |
| Acquisitions (Net) | 0 | (53.5M) | 0 | 0 | (26.53M) |
| Purchases of Investments | (1.32B) | (190.56M) | (472.87M) | (675.56M) | (389.16M) |
| Sales of Investments | 681.72M | 190.32M | 509.85M | 652.78M | 571.82M |
| Other Investing Activities | 595K | 0 | (5.65M) | 0 | 0 |
| Investing Cash Flow | (640.57M) | (59.92M) | 31.19M | (29.3M) | 147.17M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 553.91M | 0 | 0 | 23.3M | 13.68M |
| Common Stock Repurchased | (2.7M) | (85.32M) | (280.72M) | (120.29M) | (431.65M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 9.21M | 10.86M | 4.19M | (34.15M) | (46.09M) |
| Financing Cash Flow | 560.42M | (74.46M) | (276.52M) | (131.14M) | (464.06M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 46.42M | 45.22M | (61.24M) | 112.83M | 9.56M |
| Free Cash Flow | 120.88M | 173.42M | 178.3M | 266.74M | 317.5M |
Doximity, Inc.
NYSE:DOCS
Intrinsic Alpha fair value
Locked
Current Price
$30.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.